Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Atrial fibrillation: outpatient presentation and management.

Ezekowitz MD, Aikens TH, Nagarakanti R, Shapiro T.

Circulation. 2011 Jul 5;124(1):95-9. doi: 10.1161/CIRCULATIONAHA.110.967455. No abstract available.

PMID:
21730322
2.

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.

Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.

Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.

PMID:
21200007
3.

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.

Ezekowitz MD, Wallentin L, Connolly SJ, Parekh A, Chernick MR, Pogue J, Aikens TH, Yang S, Reilly PA, Lip GY, Yusuf S; RE-LY Steering Committee and Investigators.

Circulation. 2010 Nov 30;122(22):2246-53. doi: 10.1161/CIRCULATIONAHA.110.973735.

PMID:
21147728
4.

The evolving field of stroke prevention in patients with atrial fibrillation.

Ezekowitz MD, Aikens TH, Brown A, Ellis Z.

Stroke. 2010 Oct;41(10 Suppl):S17-20. doi: 10.1161/STROKEAHA.110.598201. Review.

PMID:
20876495

Supplemental Content

Loading ...
Support Center